drugset / Trial / NCT07646106
THE-0504 in Patients With Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
Single-centre, open-label, dose escalation phase I clinical trial, designed to evaluate mainly the safety and tolerability of the antitumor drug THE-0504 in patients with different types of solid tumors.
Timeline
- Start
- 2024-11-13
- Primary completion
- 2027-05-01
- Completion
- 2027-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | THE-0504 | Unknown | — | Intravenous |